City of Hope CAR T Cell Therapy for Advanced Prostate Cancer Demonstrates Positive Results in Phase 1 Clinical Trial
June 13, 2024
June 13, 2024
LOS ANGELES, California, June 13 (TNSres) -- City of Hope issued the following news release on June 12, 2024:
Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope(R), one of the largest cancer research and treatment organizations in the United States, showed that patients with advanced prostate cancer had m . . .
Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope(R), one of the largest cancer research and treatment organizations in the United States, showed that patients with advanced prostate cancer had m . . .